Heat Shock Protein 90 c-Terminal Inhibitors in Cancer Treatment
Open Access
- 16 May 2015
- journal article
- Published by Peertechz Publications Private Limited in International Journal of Pharmaceutical Sciences and Developmental Research
- Vol. 1 (1), 001
- https://doi.org/10.17352/ijpsdr.000001
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- A Novel Approach to Inhibit Heat Shock Response as Anticancer Strategy by Coumarine Compounds Containing Thiazole Skeleton.Anti-Cancer Agents in Medicinal Chemistry, 2015
- Heat Shock Protein 90 Inhibitors in OncologyCurrent Proteomics, 2014
- HSP90 Inhibitors: Current Development and Potential in Cancer TherapyRecent Patents on Anti-Cancer Drug Discovery, 2013
- The Hsp90 chaperone machinery: Conformational dynamics and regulation by co-chaperonesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Targeting the dynamic HSP90 complex in cancerNature Reviews Cancer, 2010
- Heat shock proteins; an overview.Current Pharmaceutical Biotechnology, 2010
- (−)-Epigallocatechin-3-gallate Is a Novel Hsp90 InhibitorBiochemistry, 2008